Chris Bielow
Chris Bielow
Bestätigte E-Mail-Adresse bei fu-berlin.de - Startseite
Titel
Zitiert von
Zitiert von
Jahr
OpenMS: a flexible open-source software platform for mass spectrometry data analysis
HL Röst, T Sachsenberg, S Aiche, C Bielow, H Weisser, F Aicheler, ...
Nature methods 13 (9), 741-748, 2016
2672016
Tools for label-free peptide quantification
S Nahnsen, C Bielow, K Reinert, O Kohlbacher
Molecular & Cellular Proteomics 12 (3), 549-556, 2013
2352013
Application of integrated transcriptomic, proteomic and metabolomic profiling for the delineation of mechanisms of drug induced cell stress
A Wilmes, A Limonciel, L Aschauer, K Moenks, C Bielow, MO Leonard, ...
Journal of proteomics 79, 180-194, 2013
1392013
Extensive identification and analysis of conserved small ORFs in animals
SD Mackowiak, H Zauber, C Bielow, D Thiel, K Kutz, L Calviello, ...
Genome biology 16 (1), 1-21, 2015
1152015
Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics
A Wilmes, C Bielow, C Ranninger, P Bellwon, L Aschauer, A Limonciel, ...
Toxicology in Vitro 30 (1), 117-127, 2015
942015
Proteomics quality control: quality control software for MaxQuant results
C Bielow, G Mastrobuoni, S Kempa
Journal of proteome research 15 (3), 777-787, 2016
642016
TOPPAS: a graphical workflow editor for the analysis of high-throughput proteomics data
J Junker, C Bielow, A Bertsch, M Sturm, K Reinert, O Kohlbacher
Journal of proteome research 11 (7), 3914-3920, 2012
542012
Evaluation of drug-induced neurotoxicity based on metabolomics, proteomics and electrical activity measurements in complementary CNS in vitro models
L Schultz, MG Zurich, M Culot, A da Costa, C Landry, P Bellwon, T Kristl, ...
Toxicology in Vitro 30 (1), 138-165, 2015
512015
MSSimulator: Simulation of mass spectrometry data
C Bielow, S Aiche, S Andreotti, K Reinert
Journal of proteome research 10 (7), 2922-2929, 2011
492011
On mass ambiguities in high-resolution shotgun lipidomics
C Bielow, G Mastrobuoni, M Orioli, S Kempa
Analytical chemistry 89 (5), 2986-2994, 2017
192017
Rapid and comprehensive impurity profiling of synthetic thyroxine by ultrahigh-performance liquid chromatography–high-resolution mass spectrometry
V Neu, C Bielow, I Gostomski, R Wintringer, R Braun, K Reinert, ...
Analytical chemistry 85 (6), 3309-3317, 2013
142013
Integrative functional genomics decodes herpes simplex virus 1
AW Whisnant, CS Jürges, T Hennig, E Wyler, B Prusty, AJ Rutkowski, ...
Nature communications 11 (1), 1-14, 2020
132020
Ultrahigh-performance liquid chromatography-ultraviolet absorbance detection-high-resolution-mass spectrometry combined with automated data processing for studying the kinetics …
V Neu, C Bielow, K Reinert, CG Huber
Journal of chromatography A 1371, 196-203, 2014
92014
Kinetic modelling of quantitative proteome data predicts metabolic reprogramming of liver cancer
N Berndt, A Egners, G Mastrobuoni, O Vvedenskaya, A Fragoulis, ...
British journal of cancer 122 (2), 233-244, 2020
82020
Investigation of reaction mechanisms of drug degradation in the solid state: a kinetic study implementing ultrahigh-performance liquid chromatography and high-resolution mass …
V Neu, C Bielow, P Schneider, K Reinert, H Stuppner, CG Huber
Analytical chemistry 85 (4), 2385-2390, 2013
62013
Bioinformatics for qualitative and quantitative proteomics
C Bielow, C Gröpl, O Kohlbacher, K Reinert
Bioinformatics for Omics Data, 331-349, 2011
62011
Optimal Decharging and Clustering of Charge Ladders Generated in ESI− MS
C Bielow, S Ruzek, CG Huber, K Reinert
Journal of proteome research 9 (5), 2688-2695, 2010
52010
A matter of fat: lipidomics applications in human blood and skin
M Orioli, G Mastrobuoni, C Bielow, M Carini, S Kempa
MS-Pharmaday, 2016
2016
On Mass Ambiguities in Shotgun Lipidomics
C Bielow, G Mastrobuoni, M Orioli, S Kempa
Lipidomics Forum, 2016
2016
Evaluation of drug-induced neurotoxicity based on metabolomics
L Schultz, M Culot, A Fabulas-da Costa, C Landry, P Bellwon, T Kristl, ...
2015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20